1167 related articles for article (PubMed ID: 32995872)
1. Long-term cardiometabolic disease risk in women with PCOS: a systematic review and meta-analysis.
Wekker V; van Dammen L; Koning A; Heida KY; Painter RC; Limpens J; Laven JSE; Roeters van Lennep JE; Roseboom TJ; Hoek A
Hum Reprod Update; 2020 Nov; 26(6):942-960. PubMed ID: 32995872
[TBL] [Abstract][Full Text] [Related]
2. Cardiometabolic health in offspring of women with PCOS compared to healthy controls: a systematic review and individual participant data meta-analysis.
Gunning MN; Sir Petermann T; Crisosto N; van Rijn BB; de Wilde MA; Christ JP; Uiterwaal CSPM; de Jager W; Eijkemans MJC; Kunselman AR; Legro RS; Fauser BCJM
Hum Reprod Update; 2020 Jan; 26(1):103-117. PubMed ID: 31867675
[TBL] [Abstract][Full Text] [Related]
3. Comprehensive Evaluation of Type 2 Diabetes and Cardiovascular Disease Risk Profiles in Reproductive-Age Women with Polycystic Ovary Syndrome: A Large Canadian Cohort.
Kazemi M; Pierson RA; Lujan ME; Chilibeck PD; McBreairty LE; Gordon JJ; Serrao SB; Zello GA; Chizen DR
J Obstet Gynaecol Can; 2019 Oct; 41(10):1453-1460. PubMed ID: 30712903
[TBL] [Abstract][Full Text] [Related]
4. Effect of Lifestyle Intervention on Cardiometabolic Risk Factors in Overweight and Obese Women with Polycystic Ovary Syndrome: A Systematic Review and Meta-Analysis.
Khatlani K; Njike V; Costales VC
Metab Syndr Relat Disord; 2019 Dec; 17(10):473-485. PubMed ID: 31513475
[TBL] [Abstract][Full Text] [Related]
5. [Relationship between the triglyceride/high-density lipoprotein-cholesterol ratio, insulin resistance index and cardiometabolic risk factors in women with polycystic ovary syndrome].
Roa Barrios M; Arata-Bellabarba G; Valeri L; Velázquez-Maldonado E
Endocrinol Nutr; 2009 Feb; 56(2):59-65. PubMed ID: 19627713
[TBL] [Abstract][Full Text] [Related]
6. PCOS during the menopausal transition and after menopause: a systematic review and meta-analysis.
Millán-de-Meer M; Luque-Ramírez M; Nattero-Chávez L; Escobar-Morreale HF
Hum Reprod Update; 2023 Nov; 29(6):741-772. PubMed ID: 37353908
[TBL] [Abstract][Full Text] [Related]
7. Disparities in cardio metabolic risk between Black and White women with polycystic ovary syndrome: a systematic review and meta-analysis.
Kazemi M; Kim JY; Parry SA; Azziz R; Lujan ME
Am J Obstet Gynecol; 2021 May; 224(5):428-444.e8. PubMed ID: 33316275
[TBL] [Abstract][Full Text] [Related]
8. A visceral adiposity index-related dietary pattern and the cardiometabolic profiles in women with polycystic ovary syndrome.
Ehsani B; Moslehi N; Mirmiran P; Ramezani Tehrani F; Tahmasebinejad Z; Azizi F
Clin Nutr; 2016 Oct; 35(5):1181-7. PubMed ID: 26699405
[TBL] [Abstract][Full Text] [Related]
9. Nordic dietary patterns and cardiometabolic outcomes: a systematic review and meta-analysis of prospective cohort studies and randomised controlled trials.
Massara P; Zurbau A; Glenn AJ; Chiavaroli L; Khan TA; Viguiliouk E; Mejia SB; Comelli EM; Chen V; Schwab U; Risérus U; Uusitupa M; Aas AM; Hermansen K; Thorsdottir I; Rahelić D; Kahleová H; Salas-Salvadó J; Kendall CWC; Sievenpiper JL
Diabetologia; 2022 Dec; 65(12):2011-2031. PubMed ID: 36008559
[TBL] [Abstract][Full Text] [Related]
10. Progression of glucose intolerance and cardiometabolic risk factors over a decade in Chinese women with polycystic ovary syndrome: A case-control study.
Ng NYH; Jiang G; Cheung LP; Zhang Y; Tam CHT; Luk AOY; Quan J; Lau ESH; Yau TTL; Chan MHM; Ho CS; Lim CKP; Ozaki R; Huang J; Liu KH; Tam WH; Sahota DS; Chu WCW; Goggins W; Woo J; Li TC; Chow CC; Chan JCN; Ma RCW
PLoS Med; 2019 Oct; 16(10):e1002953. PubMed ID: 31652273
[TBL] [Abstract][Full Text] [Related]
11. Levels of lipoprotein and homocysteine in non-obese and obese patients with polycystic ovary syndrome.
Yilmaz M; Biri A; Bukan N; Karakoç A; Sancak B; Törüner F; Paşaoğlu H
Gynecol Endocrinol; 2005 May; 20(5):258-63. PubMed ID: 16019370
[TBL] [Abstract][Full Text] [Related]
12. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society.
Wild RA; Carmina E; Diamanti-Kandarakis E; Dokras A; Escobar-Morreale HF; Futterweit W; Lobo R; Norman RJ; Talbott E; Dumesic DA
J Clin Endocrinol Metab; 2010 May; 95(5):2038-49. PubMed ID: 20375205
[TBL] [Abstract][Full Text] [Related]
13. Vitamin D Deficiency Is Associated With Metabolic Risk Factors in Women With Polycystic Ovary Syndrome: A Cross-Sectional Study in Shaanxi China.
Wang L; Lv S; Li F; Yu X; Bai E; Yang X
Front Endocrinol (Lausanne); 2020; 11():171. PubMed ID: 32296394
[No Abstract] [Full Text] [Related]
14. Dietary cholesterol and cardiovascular disease: a systematic review and meta-analysis.
Berger S; Raman G; Vishwanathan R; Jacques PF; Johnson EJ
Am J Clin Nutr; 2015 Aug; 102(2):276-94. PubMed ID: 26109578
[TBL] [Abstract][Full Text] [Related]
15. Assessing cardiovascular risk in Mediterranean women with polycystic ovary syndrome.
Rizzo M; Longo RA; Guastella E; Rini GB; Carmina E
J Endocrinol Invest; 2011 Jun; 34(6):422-6. PubMed ID: 20959718
[TBL] [Abstract][Full Text] [Related]
16. Triglycerides to High-Density Lipoprotein Cholesterol Ratio Can Predict Impaired Glucose Tolerance in Young Women with Polycystic Ovary Syndrome.
Song do K; Lee H; Sung YA; Oh JY
Yonsei Med J; 2016 Nov; 57(6):1404-11. PubMed ID: 27593868
[TBL] [Abstract][Full Text] [Related]
17. Cardiovascular events among reproductive and menopausal age women with polycystic ovary syndrome: a systematic review and meta-analysis.
Ramezani Tehrani F; Amiri M; Behboudi-Gandevani S; Bidhendi-Yarandi R; Carmina E
Gynecol Endocrinol; 2020 Jan; 36(1):12-23. PubMed ID: 31385729
[TBL] [Abstract][Full Text] [Related]
18. Cardiometabolic risks in polycystic ovary syndrome: long-term population-based follow-up study.
Behboudi-Gandevani S; Ramezani Tehrani F; Hosseinpanah F; Khalili D; Cheraghi L; Kazemijaliseh H; Azizi F
Fertil Steril; 2018 Dec; 110(7):1377-1386. PubMed ID: 30503137
[TBL] [Abstract][Full Text] [Related]
19. Sleep disturbances, sleep quality, and cardiovascular risk factors in women with polycystic ovary syndrome: Systematic review and meta-analysis.
Zhang J; Ye J; Tao X; Lu W; Chen X; Liu C
Front Endocrinol (Lausanne); 2022; 13():971604. PubMed ID: 36176474
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
